NCT01484392

Brief Summary

The purpose of this study is to determine which medical, demographic, and health belief factors are associated with glaucoma therapy compliance.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Aug 2006

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 1, 2006

Completed
5.3 years until next milestone

First Submitted

Initial submission to the registry

November 30, 2011

Completed
2 days until next milestone

First Posted

Study publicly available on registry

December 2, 2011

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2013

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2013

Completed
Last Updated

March 9, 2016

Status Verified

March 1, 2016

Enrollment Period

7.3 years

First QC Date

November 30, 2011

Last Update Submit

March 7, 2016

Conditions

Open Angle Glaucoma

Keywords

open angle glaucomacomplianceadherence

Outcome Measures

Primary Outcomes (2)

  • Compliance with glaucoma medication at 1 month

    Compliance is measured using the Travatan Dosing Aid, a device that records when patients administer their topical glaucoma medication.

    1 month after enrollment

  • Compliance with glaucoma medication at 3 months

    Compliance is measured using the Travatan Dosing Aid, a device that records when patients administer their topical glaucoma medication.

    3 months after enrollment

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients diagnosed with open angle glaucoma.

You may qualify if:

  • open angle glaucoma
  • be well controlled on current medical therapy
  • be using a prostaglandin analogue

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Devers Eye Institute

Portland, Oregon, 97210, United States

Location

MeSH Terms

Conditions

Glaucoma, Open-AnglePatient Compliance

Condition Hierarchy (Ancestors)

GlaucomaOcular HypertensionEye DiseasesPatient Acceptance of Health CareTreatment Adherence and ComplianceHealth BehaviorBehavior

Study Officials

  • Steven L Mansberger, MD, MPH

    Legacy Health

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Scientist

Study Record Dates

First Submitted

November 30, 2011

First Posted

December 2, 2011

Study Start

August 1, 2006

Primary Completion

December 1, 2013

Study Completion

December 1, 2013

Last Updated

March 9, 2016

Record last verified: 2016-03

Locations

US(1)